Achieving Large-Scale Ophthalmic Production

By John Teixeira, Associate Director of Commercial Operations, Jubilant HollisterStier

Safety and efficacy are a critical part of pharmaceutical manufacturing, and the risks inherent to those processes can feel even more consequential when it comes to treatments for our eyes. Ophthalmic treatments, which include solutions, drops, or ointments used to treat conditions of the eye, require a manufacturing partner with the expertise, impeccable quality assurance practices, and modern equipment necessary to ensure a safe, effective drug product.

Finding the contract manufacturing organization (CMO) best suited for your ophthalmic project necessitates a holistic evaluation of the organization’s internal processes, facilities, capacity, capabilities, and communication. By partnering with a CMO with a track record of excellence and a culture of innovation, pharmaceutical companies stand to gain a partner capable of growing and adapting alongside them for the long term.

In this article, explore innovation and managing complexity in the opthalmic space, and understand the value proposition of a CMO with 40 years of experience in ophthalmic manufacturing.